Polymyalgia Rheumatica Flashcards
Define Polymyalgia Rheumatica
Inflammatory rheumatological syndrome that manifests as a pain and morning stiffness in individuals >50
Typically involves the neck, shoulder girdle and/or pelvic girdle
Aetiology of Polymyalgia Rheumatica
Exact cause unknown
Suggested role of infectious agents e.g. adenovirus, RSV, parvovirus B18, chlamydia pneumoniae, Mycoplasma pneumoniae
Suggested role of genetic factors e.g. HLA-DRB1*04
Association with giant cell arteritis
Risk factors for Polymyalgia Rheumatica
> 50
Giant cell arteritis
Female
Symptoms of Polymyalgia Rheumatica
NO weakness
Shoulder/hip girdle stiffness (>1 hour | acute onset | bilateral)
Shoulder/hip girdle pain (>1 hour in the morning | acute onset | bilateral)
Low-grade fever
Anorexia or weight loss
Malaise
Depression
Asthenia (unaccustomed physical weakness of lack of energy)
Signs of Polymyalgia Rheumatica on examination
Tenderness over the greater trochanteric and subacromial bursae
Restricted shoulder movements/hip movements
Investigations for Polymyalgia Rheumatica
(rapid response to corticosteroids)
CRP/ESR: raised
FBC: variable, rule out myeloproliferative disease
TSH: ?hypothyroidism
USS: bursitis (trochanteric most common)| joint effusion
MRI: bursitis | joint effusion
Serum electrophoresis: normal (exclude myeloproliferative disease)
Management for initial presentation of Polymyalgia Rheumatica
- Corticosteroids e.g. prednisolone PO
- Calcium + vit D + bisphosphonates e.g. alendronic acid + calcium carbonate + colecalciferol
- NSAIDs e.g. naproxen
Second line: methotrexate + folic acid
Third: tocilizumab
Management for ongoing Polymyalgia Rheumatica
- Corticosteroids e.g. prednisolone PO
- Calcium + vit D + bisphosphonates e.g. alendronic acid + calcium carbonate + colecalciferol
- Methotrexate PO AND folic acid
- Tocilizumab
Complications of Polymyalgia Rheumatica
Chronic relapsing PMR
Giant cell arteritis
PMR-related vascular events
Corticosteroid use: risk of infection, T2DM, osteoporosis, HTN, muscle weakness, cataracts, glaucoma, skin changes
Methotrexate: methotrexate, oral ulcers, myelosuppression, hepatotoxicity, interstitial lung disease
Prognosis of Polymyalgia Rheumatica
Overall is good
Response typically within 24-72 hours
Relapses or symptom exacerbations are common